학술논문

Safety, tolerability, and clinical activity of selinexor in combination with pembrolizumab in treatment of metastatic non–small cell lung cancer
Document Type
Article
Source
In: Cancer. (Cancer, 1 September 2023, 129(17):2685-2693)
Subject
Language
English
ISSN
10970142
0008543X